The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Louis M. Staudt(National Cancer Institute), Trond Stokke, Dennis D. Weisenburger(University of Nebraska Medical Center), Joseph M. Connors, Lauren Averett, Elı́as Campo(Hospital Clínic de Barcelona), Elaine M. Hurt, Randy D. Gascoyne(BC Cancer Agency), Dan L. Longo(Harvard University), John Powell(National Institutes of Health), Timothy C. Greiner(University of Nebraska Medical Center), Richard H. Simon(University of Michigan), Wyndham H. Wilson(National Institutes of Health), Bhavana J. Davé, Peter Krajči, Jamés O. Armitage(University of Nebraska Medical Center), P L Duffey, German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Julie M. Vose(University of Nebraska Medical Center), Jan Delabie, Jena M. Giltnane, George W. Wright(National Cancer Institute), Harald Holte(Oslo University Hospital), Elaine S. Jaffe(National Cancer Institute), Liming Yang(China Three Gorges Corporation (China)), Hong Zhao(Northwestern University), Thomas P. Miller(Queen Elizabeth University Hospital), Richard D. Klausner(Memorial Sloan Kettering Cancer Center), James C. Lynch, H. K. Müller-Hermelink(University of Würzburg), Warren G. Sanger, M. Leblanc, Emilio Montserrat, Stein Kvaløy(Norwegian Cancer Society), Richard I. Fisher(University of Rochester), Thomas M. Grogan, Armando López‐Guillermo(Barcelona Supercomputing Center), Erlend B. Smeland(Norwegian Cancer Society), Wing C. Chan(Ontario Institute for Cancer Research)
New England Journal of Medicine
June 20, 2002
Cited by 3,858


Related Papers